Focused Wealth Management, Inc Vertex Pharmaceuticals Inc Transaction History

Focused Wealth Management, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$314.42 - $351.91 $2,515 - $2,815	8 Added 17.78%	53 $18,000
Q1 2023 Apr 13, 2023	SELL	$283.23 - $323.1 $62,310 - $71,082	-220 Reduced 83.02%	45 $14,000
Q4 2022 Jan 13, 2023	BUY	$285.76 - $321.48 $59,152 - $66,546	207 Added 356.9%	265 $0
Q4 2021 Jan 31, 2022	SELL	$177.01 - $223.45 $2,655 - $3,351	-15 Reduced 20.55%	58 $13,000
Q3 2021 Oct 12, 2021	BUY	$181.39 - $202.99 $2,358 - $2,638	13 Added 21.67%	73 $13,000
Q2 2021 Jul 15, 2021	BUY	$187.49 - $221.1 $4,687 - $5,527	25 Added 71.43%	60 $12,000
Q1 2021 May 03, 2021	BUY	$207.02 - $241.31 $7,245 - $8,445	35 New	35 $8,000
Q3 2019 Nov 06, 2019	SELL	$166.23 - $187.09 $10,804 - $12,160	-65 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	65	65 $8,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Focused Wealth Management, Inc with notifications on news.